What is Foolsaurus?

It's a glossary of investing terms edited and maintained by our analysts, writers and YOU, our Foolish community.


Repligen (Nasdaq:RGEN) is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.

Company Description

Related Companies

Recent Mentions on Fool.com